Association for Molecular Pathology
Add to Favorites Newsroom RSS Share
fb-shareAssociation for Molecular Pathology
Bethesda, MD USA

Our News on Newswise

Association for Molecular Pathology Announces 2019 Award Recipients

AMP has announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award. These prestigious accolades will be presented this November during AMP’s 25th Annual...
19-Sep-2019 9:00 AM EDT Add to Favorites

AMP Recommends Clinical Pharmacogenomic Testing Best Practices to Preserve Broad Access and Improve Patient Care

AMP has published a new position statement for pharmacogenomic testing. Based on a recent assessment of the current market landscape, the statement includes a list of criteria for laboratories to follow for these types of tests to ensure responsible...
4-Sep-2019 9:45 AM EDT Add to Favorites

AMP Bolsters Position on Consumer Genomic Testing

AMP has revised its official position for all consumer genomic testing. Based on a recent assessment of the current market landscape and privacy best practices, the latest position statement features an expanded list of conditions that must be met...
10-Jun-2019 11:05 AM EDT Add to Favorites

Association for Molecular Pathology Expresses Serious Concerns with Congress’ Attempt to Resurrect Human Gene Patenting Debate and Reverse Settled Supreme Court Ruling

AMP has expressed serious concerns with Congress’ recent proposal to amend Section 101 of the Patent Act. If enacted, the draft legislation would overturn 150 years of patent case law and permit patenting of human genes and naturally-occurring...
4-Jun-2019 10:50 AM EDT Add to Favorites

AMP Recommends Minimum Set of Alleles for All Clinical CYP2C9 Genotyping Testing

A new joint report from AMP and CAP shares consensus, evidence-based recommendations to aid in the design and validation of clinical CYP2C9 assays, promote standardization of testing across different laboratories and improve patient care.
9-May-2019 10:05 AM EDT Add to Favorites

More than 60 Leading Health Care Organizations Call on CMS to Maintain Coverage for Medically Necessary Cancer Testing

Leading health care companies and organizations representing patients, providers, academic medical centers, laboratories, and diagnostic manufacturers urged the Centers for Medicare and Medicaid Services to revise its interpretation of the National...
1-Feb-2019 12:00 PM EST Add to Favorites

Association for Molecular Pathology Announces 2018 Award Recipients

AMP has announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award. These prestigious accolades will be presented in November during the AMP 2018 Annual...
22-Aug-2018 2:05 PM EDT Add to Favorites

AMP Addresses Clinical Relevance of DNA Variants in Chronic Myeloid Neoplasms

AMP has published consensus, evidence-based recommendations to aid clinical laboratory professionals with the management of most Chronic Myeloid Neoplasms (CMNs) and development of high-throughput pan-myeloid sequencing testing panels.
21-Aug-2018 3:05 PM EDT Add to Favorites


see all news

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

The Association for Molecular Pathology (AMP)was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,500+ members practice in the various disciplines of molecular diagnostics, including bioinformatics, infectious diseases, inherited conditions, and oncology. They include individuals from academic and community medical centers, government, and industry; including pathologist and doctoral scientist laboratory directors; basic and translational scientists; technologists; and trainees. Through the efforts of its Board of Directors, Committees, Working Groups, and members, AMP is the primary resource for expertise, education, and collaboration in one of the fastest growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high quality, appropriate testing.

Contacts

Laurie Menser
Director of Strategic Development

lmenser@amp.org

301-634-7969

TaNika Switzer
Project Coordinator

tswitzer@amp.org

301-634-7934

Mary Williams
Executive Director

mwilliams@amp.org

301-634-7921

Twitter twitter-icon

Chat now!
0.59336